Adamantane 281-23-2
  • Adamantane 281-23-2 Adamantane 281-23-2

Adamantane 281-23-2

Nabata ịzụta Adamantane 281-23-2 n'aka anyị. Amantadine, nke a makwaara dị ka amantadine ma ọ bụ tricyclodecylamine, bụ nke mbụ e ji mee ihe dị ka ọgwụ mgbochi nje ma mesịa chọpụta na ọ nwere mmetụta mgbochi ọrịa Parkinson. 1. Ọrịa mgbochi Parkinson: Mgbe amantadine batara n'ụbụrụ, Chemicalbook nwere ike ịkwalite ntọhapụ nke ndị na-ebugharị dopamine site na neurons dopaminergic ma gbochie nlọghachi nke dopamine. Ọzọkwa, Chemicalbook nwere ike kpalie ndị na-anabata dopamine ozugbo, na arụmọrụ ya adịghị mma

Zipu ajụjụ

Nkọwa ngwaahịa

Kwere Chemical bụ Adamantane 281-23-2 ndị na-emepụta ihe na ndị na-ebubata ya na China ndị nwere ike ibu ibu Adamantane 281-23-2. Shandong kwere


Adamantane 281-23-2 Nkọwa kemịkalụ

Aha ngwaahịa

Adamantane

Usoro

C10H16

Ibu molekụla

136.23

CAS NO.

281-23-2

Ọnụọgụ

500KG


Ihe

Nkọwapụta

Nsonaazụ

Ọdịdị

kristal ọcha ntụ ntụ

Na-akwado

Nyocha

â¥99%

Na-akwado

Ebe mgbaze

209-212 Celsius C (sbl.) (ọkụ)

Na-akwado

Njupụta

1,07 g/cm3

Na-akwado

NKWUBIOKWU

Nsonaazụ dabara na ọkọlọtọ


Adamantane 281-23-2 Njirimara Chemical

Okwu: TRICYCLO[3.3.1.1]DECANE; TRICYCLO[3.3.1.13,7]DECANE; TRICYCLODECANE;[6]diadamantane;3,5,1,7-[1,2,3,4]butanetetraylChemicalbooknaphthalene,deancatanhydro-; ;decahydro-3,5,1,7-[1,2,3,4]butatetraylnaphthalene;Tricyclo(3,3,1,1,3,7) -decane


CAS:

Usoro ihe omimi:

Arọ molikula:

EINECS: 206-001-4

Ebe esi mmiri:

Njupụta:

Ọnọdụ nchekwa:

Ndekọ ntụgharị uche:

Ndụ nchekwa: afọ 2


Adamantane 281-23-2 Chemical

Adamantane CAS

Adamantane CAS



Mkpado na-ekpo ọkụ: Adamantane 281-23-2, Ndị na-emepụta ihe, ndị na-ebubata, ndị na-ere ahịa, ụlọ ọrụ, na ngwaahịa, mere na China, China, ọnụ ala, ego, àgwà, API, nyocha na mmepe, nchịkọta omenala.

Mkpado ngwaahịa

Ụdị emetụtara

Zipu ajụjụ

Biko nweere onwe gị ịnye ajụjụ gị n'ụdị dị n'okpuru. Anyị ga-aza gị n'ime awa 24.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept